Navigation Links
LensAR Advances Commercialization Efforts With Appointment of Key Sales and Marketing Executives
Date:3/23/2010

WINTER PARK, Fla., March 23 /PRNewswire/ -- LensAR, Inc., a leading developer of next generation laser technology for cataract surgery and other ocular applications, today announced the appointment of Michael O'Rourke as the company's senior vice president of global sales and marketing and Ron Goldrich as senior vice president of sales.  The addition of Mr. O'Rourke and Mr. Goldrich, who both possess extensive product commercialization, sales and marketing experience in the ophthalmic, pharmaceutical and medical device industries, represents a significant step in LensAR's planned efforts to commercialize its revolutionary LensAR Laser System.  The LensAR Laser System is being developed to enable novel "All Laser" procedures in the areas of cataract surgery and presbyopia.

"Michael O'Rourke brings to LensAR a wide range of ophthalmology strategic planning, business development and diverse product launch experience including cataract, retina and refractive surgery dating back to the mid 1990's.  His successful growth into ophthalmic executive management positions bodes well for LensAR in meeting the challenges of brand and infrastructure growth in this exciting new market," said Randy Frey, founder and chief executive officer of LensAR.  "I have had the privilege of knowing Ron Goldrich from my prior company Autonomous.  Ron was our company's leader in driving laser system sales growth.  I am very excited to have Ron on board with LensAR and know that he will absolutely deliver."

Mr. O'Rourke has 25 years of global healthcare experience within the pharmaceutical and medical device markets including 15 years focused on global ophthalmology with Chiron Vision International and Bausch & Lomb.  He has managed 26 individual brands, played a key role in 16 drug and device regulatory approvals and directed twelve major product launches including multiple unique ocular drug delivery technologies.  During his ten years with Bausch & Lomb, Mr. O'Rourke held several key management positions including general manager with responsibility for leading the growth of the company's U.S. pharmaceuticals division, as well as global vice president of strategy for both the medical device and pharmaceutical divisions.  At Chiron Vision, he successfully built the company's European marketing business and integrated a total of four acquired European companies and their related anterior, posterior and refractive ocular business portfolios.  Mr. O'Rourke currently serves as chairman of the board for the Lions Eye Foundation in Tampa, Florida, the world's largest eye bank.

With more than 30 years of relevant industry experience, Mr. Goldrich previously served as vice president of sales, North America for Eyeonics Corporation where he was responsible for creating and managing the company's sales force and establishing and leveraging relationships with key opinion leaders to drive significant business growth.  Following the acquisition of Eyeonics by Bausch & Lomb, he was appointed vice president of sales and strategic accounts for the Eastern United States.  Mr. Goldrich also previously worked as director of sales and strategic accounts for the South Eastern United States for Intralase Corporation where he was credited with more than doubling revenue and market share in his first year.  During his career, Mr. Goldrich has also held key sales management positions with a number of other ophthalmic companies including Summit Autonomous, Autonomous Technologies, Chiron Vision, American Medical Optics and Allergan Pharmaceuticals.

About LensAR, Inc.

LensAR, Inc. is a leading developer of next generation laser technology for cataract surgery and other ocular applications, including presbyopia.  The LensAR Laser System, which integrates an advanced ultra short pulse laser with propriety ocular measurement and laser scanning technologies, is being designed to allow physicians to perform several of the steps in cataract surgery (capsulotomy, lens fragmentation, precise astigmatic corrections and unique clear corneal incisions) in a single laser procedure.   In addition to advancing its laser technology in the area of cataract surgery, the company is also developing the LensAR Laser System for the treatment of presbyopia.

For more information on LensAR and its laser technology, please visit our website at www.lensar.com

SOURCE LensAR, Inc.

Back to top

RELATED LINKS
http://www.lensar.com/

'/>"/>

SOURCE LensAR, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LenSar: New Laser Cure for Cataracts
2. New MedPredict Report Highlights Recent Advances in Management of Malignant Hematology
3. Greenway Medical Technologies Advances Interoperability at Integrating the Healthcare Enterprise (IHE) North America Connectathon
4. Neurocrine Advances VMAT2 Inhibitor Program
5. Medco Reforming Healthcare with Smarter Medicine; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost
6. Advances in Treating Hip Pain To Be Focus of Hip Arthroscopy Meeting
7. Hamon Tower Features Critical Care Advances, Potential for Reduced Costs
8. Research Consortium Advances Understanding of Cervical Spine Injuries in Children Involved in Motor Vehicle Crashes
9. Lilly Advances Second Alzheimers Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
10. Cylene to Present Advances in its Oral Inhibitor of CK2 at AACR Annual Meeting
11. Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets has announced ... Growth and Demand Forecast to 2022" report to their offering. ... The global wound care market ... at a CAGR of 6.7% during 2016-2022 Among the various ... largest share in the global market in 2015. Among the various applications, ...
(Date:3/24/2017)... -- FinancialBuzz.com News Commentary  ... According to new data published ... the legal cannabis market is projected to continue to grow ... from the current presidential administration. The report created by Arcview,s ... of growth in this industry are the passage and subsequent ...
(Date:3/24/2017)... -- Global Ampoules Market report provides a ... and industry chain structure. The Ampoules market analysis is ... landscape analysis, and major regions, development status. ... Complete ... 10 company profiles and 183 tables and figures is ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... to prep patients for colonoscopy at the HyGIeaCare® Center that is to be ... FL. , The HyGIeaCare® Prep, cleared by the U.S. Food and ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion ... to Walk with God #TruthwithGrace” is the creation of published author Lea Michelle ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of Saints: A ... God in congregations across the United States. “The Communion of Saints” is ... who has served congregations in seven states throughout his long career of devotion ...
(Date:3/23/2017)... ... , ... A recent report from the National Council on Teacher Quality (NCTQ) ... suggests, based on a review of GPA and SAT/ACT requirements at 221 institutions in ... It argues that this higher bar should be set by states, by the Council ...
(Date:3/23/2017)... TX (PRWEB) , ... March 23, 2017 , ... ... clinic, located at 960 Gruene Road in Building 2. The clinic is the group’s ... Andrew Bennett, PT, says opening the company’s second New Braunfels location brings things full ...
Breaking Medicine News(10 mins):